News
41m
Barchart on MSNVertex Pharmaceuticals’ Q1 2025 Earnings: What to ExpectWith a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company ...
Vertex Pharmaceuticals got a healthy boost on Tuesday, with shares climbing nearly 3% thanks to a double dose of analyst ...
Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotech's shares closed the day nearly 3% ...
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results